ZyVersa Therapeutics (ZVSA) Short Interest Ratio & Short Volume → Gold Set to EXPLODE! (From Gold Safe Exchange) (Ad) Free ZVSA Stock Alerts $4.27 +0.01 (+0.23%) (As of 05/29/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends ZyVersa Therapeutics Short Interest DataCurrent Short Interest14,900 sharesPrevious Short Interest15,600 sharesChange Vs. Previous Month-4.49%Dollar Volume Sold Short$73,606.00Short Interest Ratio0.0 Days to CoverLast Record DateMay 15, 2024Outstanding Shares830,000 sharesFloat Size833,900 sharesShort Percent of Float1.79%Today's Trading Volume29,785 sharesAverage Trading Volume278,900 sharesToday's Volume Vs. Average11% Short Selling ZyVersa Therapeutics ? Sign up to receive the latest short interest report for ZyVersa Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartZVSA Short Interest Over TimeZVSA Days to Cover Over TimeZVSA Percentage of Float Shorted Over Time Ad Crypto 101 MediaTech GIANT’s Plans to Revolutionize Crypto…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. ZyVersa Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/202414,900 shares $73,606.00 -4.5%1.8%0 $4.94 4/30/202415,600 shares $82,524.00 -96.6%2.1%0 $5.29 4/15/2024460,800 shares $292,838.40 -20.6%6.1%0.2 $0.64 3/31/2024580,600 shares $435,450.00 -10.1%8.1%0.2 $0.75 3/15/2024646,000 shares $504,203.00 -45.7%16.9%0.2 $0.78 2/29/20241,190,000 shares $1.31 million +619.5%74.4%0.4 $1.10 Get the Latest News and Ratings for ZVSA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ZyVersa Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/15/2024165,400 shares $95,402.72 -14.5%10.3%0.1 $0.58 1/31/2024193,500 shares $110,314.35 +545.0%1.5%0.2 $0.57 1/15/202430,000 shares $22,608.00 -51.6%0.2%0 $0.75 12/31/202362,000 shares $55,800.00 +38.1%0.5%0.1 $0.90 12/15/202344,900 shares $34,797.50 +152.3%0.4%0.1 $0.78 11/30/202317,800 shares $40,495.00 -99.2%0.1%0 $2.28 11/15/20232,300,000 shares $191,130.00 +25.7%18.3%0.3 $0.08 10/31/20231,830,000 shares $150,060.00 -26.8%14.6%0.3 $0.08 10/15/20232,500,000 shares $324,750.00 +86.6%19.9%0.5 $0.13 9/30/20231,340,000 shares $173,530.00 -63.1%10.7%0.3 $0.13 9/15/20233,630,000 shares $540,870.00 +1,168.8%28.9%0.8 $0.15 8/31/2023286,100 shares $40,683.42 -9.2%2.3%0.1 $0.14 8/15/2023315,100 shares $50,416.00 -52.4%2.5%0.2 $0.16 7/31/2023662,600 shares $114,298.50 -43.9%5.3%0.3 $0.17 7/15/20231,180,000 shares $293,466.00 +148.0%N/A0.4 $0.25 6/30/2023475,900 shares $116,833.45 -37.4%N/A0.2 $0.25 6/15/2023760,400 shares $250,932.00 +6.7%N/A0.4 $0.33 5/31/2023712,400 shares $260,738.40 +178.9%N/A0.4 $0.37 5/15/2023255,400 shares $110,409.42 No ChangeN/A0.2 $0.43 ZVSA Short Interest - Frequently Asked Questions What is ZyVersa Therapeutics' current short interest? Short interest is the volume of ZyVersa Therapeutics shares that have been sold short but have not yet been covered or closed out. As of May 15th, investors have sold 14,900 shares of ZVSA short. 1.79% of ZyVersa Therapeutics' shares are currently sold short. Learn More on ZyVersa Therapeutics' current short interest. What is a good short interest percentage for ZyVersa Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.79% of ZyVersa Therapeutics' floating shares are currently sold short. Is ZyVersa Therapeutics' short interest increasing or decreasing? ZyVersa Therapeutics saw a decrease in short interest in May. As of May 15th, there was short interest totaling 14,900 shares, a decrease of 4.5% from the previous total of 15,600 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is ZyVersa Therapeutics' float size? ZyVersa Therapeutics currently has issued a total of 830,000 shares. Some of ZyVersa Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. ZyVersa Therapeutics currently has a public float of 833,900 shares. How does ZyVersa Therapeutics' short interest compare to its competitors? 1.79% of ZyVersa Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to ZyVersa Therapeutics: Cyclacel Pharmaceuticals, Inc. (10.61%), 60 Degrees Pharmaceuticals, Inc. (0.98%), Mustang Bio, Inc. (2.73%), Phio Pharmaceuticals Corp. (3.84%), Aptevo Therapeutics Inc. (1.33%), Seelos Therapeutics, Inc. (4.21%), Virios Therapeutics, Inc. (0.52%), Sonoma Pharmaceuticals, Inc. (0.48%), Biodexa Pharmaceuticals Plc (24.96%), Longeveron Inc. (3.09%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short ZyVersa Therapeutics stock? Short selling ZVSA is an investing strategy that aims to generate trading profit from ZyVersa Therapeutics as its price is falling. ZVSA shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ZyVersa Therapeutics? A short squeeze for ZyVersa Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ZVSA, which in turn drives the price of the stock up even further. How often is ZyVersa Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ZVSA, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Kiora Pharmaceuticals Short Interest Edesa Biotech Short Interest FSD Pharma Short Interest Imunon Short Interest RedHill Biopharma Short Interest Pieris Pharmaceuticals Short Interest TransCode Therapeutics Short Interest MIRA Pharmaceuticals Short Interest Elevai Labs Short Interest Guardion Health Sciences Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ZVSA) was last updated on 5/30/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersWrite this ticker symbol down…StocksToTradeThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarBiden Nomination CANCELED?The Freeport SocietyMust-See: Elon’s New Invention is Absolutely InsaneInvestorPlaceWho are Nvidia’s New Silent Partners?Weiss RatingsThe 7th Trillion Dollar Company?The Oxford ClubDo This Before July 30 2024 To Claim Trump’s Gift Wealthpin Pro Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ZyVersa Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.